南場　研一　業績集

英文業績（２００１年から現在まで）

IF (impact factor)：　2022年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

7

25.0

3.6

Corresponding author

31

67.2

2.2

Second author

10

39.6

4.0

その他

97

451.2

4.7

英文全業績

145

583.0

4.0

 

  1. Nakai S, Takeuchi M, Usui Y, Namba K, Suzuki K, Harada Y, Kusuhara S, Kaburaki T, Tanaka R, Takeuchi M, Mizuki N, Nakai K, Goto H, Herbort CP Jr. Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study. Ocul Immunol Inflamm. 2024; 32: 367-375
  2. Arita T, Namba K, Iwata D, Suzuki K, Ogino Y, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis. BMC Ophthalmol. 2023; 23:424
  3. Matsumoto K, Kase S, Namba K, Iwata D, Matsuno Y, Ishida S. A case of intraocular metastasis of lung cancer diagnosed using cell block preparation of vitreous humor. Cancer Diagn Progn. 2023; 3: 130-134
  4. Ogino Y, Namba K, Iwata D, Suzuki K, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination. BMC Ophthalmol. 2023; 23: 233
  5. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease. Ocul Immunol Inflamm. 2023; 31: 501-505
  6. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS One. 2023; 18: e0294745
  7. Takeuchi M, Usui Y, Namba K, Keino H, Takeuchi M, Takase H, Kamoi K, Hase K, Ito T, Nakai K, Maruyama K, Kobayashi E, Mashimo H, Sato T, Ohguro N, Hori J, Okada AA, Sonoda KH, Mizuki N, Goto H. Ten-year follow-up of infliximab treatment for uveitis in Behcet disease patients: A multicenter retrospective study. Front Med. 2023; 10: 1095423
  8. Fukutsu K, Kase S, Iwata D, Suzuki K, Namba K, Ishida S. The expression of matrix metalloproteinases in eyes with intraocular lymphoma. Ocul Immunol Inflamm. 2022; 30:1798-1802
  9. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2022; 46: 1908-1916
  10. Iwata D, Namba K, Yamamoto T, Mizuuchi K, Saito W, Ohno S, Kitaichi N, Ishida S. Recent clinical features of intraocular inflammation in Hokkaido, Japan - comparison with the previous decade. Ocul Immunol Inflamm. 2022; 30: 848-854
  11. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida S. Diagnostic accuracy of cell block preparations and clinical features affecting it in vitreoretinal lymphoma. J Clin Med. 2022; 11: 1391
  12. Kijima R, Shinmei Y, Chin S, Kanaya R, Shinkai A, Ohguchi T, Namba K, Ishida S. Long-term Outcomes of Modified 360-degree Suture Trabeculotomy for Uveitic Glaucoma Compared with Primary Open Angle Glaucoma. J Glaucoma. 2022; 31: 682-688
  13. Miyazaki D, Fukushima A, Uchio E, Shoji J, Namba K, Ebihara N, Takamura E, Fukuda K, Matsuda A, Okamoto S, Fukagawa K, Fujishima H, Ohno S, Ohashi Y; Japanese Society of Ocular Allergology, The Japanese Society of Allergology. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021. Allergol Int. 2022; 71: 459-471
  14. Namba K, Kaburaki T, Tsuruga H, Ogawa Y, Iwashita E, Goto H. Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients. Ophthalmol Ther. 2022; 11:1147-1161
  15. Namba K, Takase H, Usui Y, Nitta F, Maruyama K, Kusuhara S, Takeuchi M, Azumi A, Yanai R, Kaneko Y, Hasegawa E, Nakai K, Tsuruga H, Morita K, Kaburaki T. Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis. Jpn J Ophthalmol. 2022; 66: 130-141
  16. Suzuki K, Ishihara M, Namba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, Ishida S. Clinical features of ocular sarcoidosis: severe, refrectory, and prolonged inflammation. Jpn J Ophthalmol. 2022; 66: 447-454
  17. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022; 25: 101363
  18. Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma. BMC Ophthalmol. 2022; 22: 428
  19. Umazume A, Ohguro N, Okada AA, Namba K, Sonoda KH, Tsuruga H, Morita K, Goto H. Use of systemic corticosteroid in patients newly registered at a claims datebase with a diagnosis of non-infectious uveitis: result from a real-world claims database analysis. Jpn J Ophthalmol. 2022; 66: 394-404
  20. Weng X, Iwata D, Namba K, Suzuki K, Mizuuchi K, Nakamura H, Atsumi T, Ishida S. Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report. Am J Ophthalmol Case Rep. 2022; 25: 101333
  21. Yamashita Y, Hashimoto Y, Namba K, Mizuuchi K, Ishida S. Optic nerve head microcirculation in eyes with Vogt-Koyanagi-Harada disease accompanied by anterior ischemic optic neuropathy. Case Rep Ophthalmol. 2022; 12: 899-908
  22. Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, Ishida S. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022; 28: 101732
  23. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2021; 46: 1908-1916
  24. Kanaya R, Kijima R, Shinmei Y, Shinkai A, Ohguchi T, Namba K, Chin S, Ishida S. Surgical Outcomes of Trabeculectomy in Uveitic Glaucoma: A Long-Term, Single-Center, Retrospective Case-Control Study. J Ophthalmol. 2021; 2021: 5550776
  25. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagnosis & Prognosis. 2021; 1: 69-75
  26. Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H; JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021; 65: 184-190
  27. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 971-978
  28. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65: 191-198
  29. Terada Y, Kaburaki T, Takase H, Goto H, Nakano S, Inoue Y, Maruyama K, Miyata K, Namba K, Sonoda KH, Kaneko Y, Numaga J, Fukushima M, Horiguchi N, Ide M, Ehara F, Miyazaki D, Hasegawa E, Mochizuki M. Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus. Am J Ophthalmol. 2021; 227: 191-200
  30. Umazume A, Ohguro N, Okada AA, Namba K, Sonoda K, Tsuruga H, Morita K, Goto H. Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database. Jpn J Ophthalmol. 2021; 65: 657-665
  31. Balt J, Uehara O, Abiko Y, Jamyanjav B, Jav S, Nagasawa T, Horie Y, Mori M, Fujita M, Lennikov A, Ohta T, Hiraoka M, Iwata D, Namba K, Ohno S, Kitaichi N. Alteration of oral flora in Mongolian patients with Behcet’s disease – A multicenter study. Clin Exp Rheumatol. 2020; 127: 80-85
  32. Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020; 20: 94
  33. Futakuchi A, Morimoto T, Ikeda Y, Tanihara H, Inoue T; ROCK-S study group collaborators (Aihara M, Arimura S, Fukuchi T, Higashide T, Honjo M, Inatani M, Inoue K, Ishida K, Ishikawa M, Iwao K, Kakimoto H, Kawase K, Kimura A, Kinoshita S, Kiuchi Y, Kokubun T, Maekawa S, Miyata K, Mori K, Nakamura S, Nakamura N, Nakamura M, Nakazawa T, Namba K, Nishida T, Ohguro N, Ohtani S, Okumichi H, Sakamoto M, Sawada A, Shiokawa M, Sotozono C, Suetake A, Sugiyama K, Takemoto Y, Tokumo K, Tomita G, Tsuzaki S, Udagawa S, Ueno M, Yokoyama Y, Yoshitomi T, Yuasa Y) . Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study. Sci Rep. 2020; 10: 10308
  34. Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S. Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma. Ocul Immunol Inflamm. 2020; 28: 147–155
  35. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  36. Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, Kolek V, Benicka A, Yamane T, Shibuya E, Yoshino A, Isomoto A, Ota M, Yatsu K, Shijubo N, Nagai S, Yamaguchi E, Yamaguchi T, Namba K, Kaburaki T, Takase H, Morimoto SI, Hori J, Kono K, Goto H, Suda T, Ikushima S, Ando Y, Takenaka S, Takeuchi M, Yuasa T, Sugisaki K, Ohguro N, Hiraoka M, Kitaichi N, Sugiyama Y, Horita N, Asukata Y, Kawagoe T, Kimura I, Ishido M, Inoko H, Mochizuki M, Ohno S, Bahram S, Remmers EF, Kastner DL, Mizuki N. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis. Commun Biol. 2020; 3: 465
  37. Miyazaki D, Fukagawa K, Okamoto S, Fukushima A, Uchio E, Ebihara N, Shoji J, Namba K, Shimizu Y. Epidemiological aspects of allergic conjunctivitis. Allergol Int. 2020; 69: 487-495
  38. Miyazaki D, Shimizu D, Fukushima A, Ebihara N, Uchio E, Shoji J, Namba K, Inoue Y, Ohashi Y, Okamoto S, Takamura E, Fujishima H. Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases. Jpn J Ophthalmol. 2020; 64: 568-576
  39. Miyazaki D, Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Satake Y, Shoji J, Namba K, Fukagawa K, Fukushima A, Fujishima H; Japanese Society of Ocular Allergology; Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020; 69: 346-355
  40. Mizuuchi K, Saito W, Namba K, Ishida S. Multiple evanescent white dot syndrome and panuveitis: a case report. J Ophthalmic Inflamm Infect. 2020; 10: 26
  41. Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimiizu N, Sugita S, Nakamuro T, Hosogai M, Nakatani Y, Sonoda KH, Hasegawa E, Takeda A, Myojin S, Yanai R, Uchi SH, Nagata K, Kaburaki T, Tanaka R, Goto H, Kezuka T, Usui Y, Yamakawa N, Fukuda K, Ishida W, Maruyama K, Hariya T, Namba K, Iwata D, Iwasaki T, Nejima R, Tomomatsu T, Aoki T, Kitaichi N, Horie Y, Takahashi M, Kurimoto Y, Hirami Y. Evaluation of a multiplex Strip PCR test for infectious uveitis: a prospective multi-center study. Am J Ophthalmol. 2020; 213: 252-259
  42. Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, Mizuki N. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japan. PLoS One. 2020; 15: e0233464
  43. Goto H, Zako M, Namba K, Hashida N, Kaburaki T, Miyazaki M, Sonoda KH, Abe T, Mizuki N, Kamoi K, Brézin AP, Dick AD, Jaffe GJ, Nguyen QD, Inomata N, Kwatra NV, Camez A, Song AP, Kron M, Tari S, Ohno S. Adalimumab in active and inactive, non-infectious uveitis: global results from the VISUAL I and VISUAL II trials. Ocul Immunol Inflamm. 2019; 27: 40-50
  44. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
  45. Miyazawa H, Fujita Y, Muramatsu K, Iwata H, Nomura T, Namba K, Hoshina D, Shimizu H. Refractory juvenile psoriatic uveitis without arthritis: A literature review. J Eur Acad Dermatol Venerol, 2019; 34: e173-e175
  46. Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA; International Workshop on Ocular Sarcoidosis Study Group(Accorinti M, A Acharya N, Asyari F, Babu K, Basu S, Biswas J, Bodaghi B, Chee SP, Chhabra R, Cowan CL, Goldstein DA, Goto H, Hwang YS, Ishihara M, Jabs DA, P Jones N, Kaburaki T, Kawashima H, Khairallah M, LeHoang P, Maruyama K, McCluskey P, Mochizuki M, Murray PI, Namba K, Ohguro N, Ohno S, Okada AA, Rao NA, Sakai T, Sheu SJ, Smith JR, Sonoda KH, Sukavatcharin S, Takase H, Tugal-Tutkun I, Gon Yu H, Zierhut M). Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019; 103: 1418-1422
  47. Ohno T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Association study of ARMC9 gene variants with Vogt-Koyanagi-Harada disease in Japanese patients. Ocul Immunol Inflamm. 2019; 27: 699-705
  48. Shibata Y, Kase S, Namba K, Ishida S. A case of nodular posterior scleritis simulating intraocular tumor. Int J Ophthalmol. 2019; 12: 685-688
  49. Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis. Curr Eye Res. 2019; 44: 796-805
  50. Takeuchi M, Kanda T, Kaburaki T, Tanaka R, Namba K, Kamoi K, Maruyama K, Shibuya E, Mizuki N. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study. Medicine (Baltimore). 2019; 98: e14668
  51. Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S. Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis. Am J Ophthalmol Case Rep. 2019; 14: 87-91
  52. Sakai M, Takase H, Namba K, Mizuuchi K, Iwata D, Ishida S. Two cases of cytomegalovirus panuveitis in immunocompetent patients. Am J Ophthalmol Case Rep. 2018; 10: 189-191
  53. Higashi K, Meguro A, Takeuchi M, Yamane T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Tsuneoka H, Keino H, Okada AA, akeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Investigation of association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. Ophthalmic Genet. 2017; 38: 187-189
  54. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017; 12: e0172612
  55. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  56. Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N. Serial observation and clinical features of uveitis in Hokkaido, Japan. Ocul Immunol Inflamm. 2017; 25: S15-18
  57. Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  58. Kanno-Okada H, Takakuwa E, Tagawa Y, Kase S, Hatanaka KC, Hatanaka Y, Namba K, Mitsuhashi T, Matsuno Y. Cytopathologic findingsof cell block materials from the vitreous: Diagnostic distinction between intraocular lymphoma and non-lymphomatous diseases. Pathol Int. 2017; 67: 342-349
  59. Miyazaki D, Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Shoji J, Takamura E, Nakagawa Y, Namba K, Fujishima H. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Ophthalmology. 2017; 124: 287-294
  60. Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Allergol Int. 2017; 66: 338-343
  61. Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, Namba K, Fukagawa K, Fukushima A, Fujishima H. Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017; 66: 220-229
  62. Horie Y, Kitaichi N, Hijioka K, Sonoda K, Saishin Y, Kezuka T, Goto H, Takeuchi M, Nakamura S, Kimoto T, Shimakawa M, Kita M, Sugita S, Mochizuki M, Hori J, Iwata M, Shoji J, Fukuda M, Kaburaki T, Numaga J, Kawashima H, Fukushima A, Joko T, Takai N, Ozawa Y, Meguro A, Mizuki N, Namba K, Ishida S, Ohno S. Ocular Behçet’s disease is less complicated with allergic disorders. A nationwide survey in Japan. Clin Exp Rheumatol. 2016; 102: 1100-1105
  63. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S. Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol. 2016; 11: 29
  64. Sakurai Y, Namba K, Mizuuchi K, Nomura T, Ishida S. A case of severe panuveitis associated with psoriasis vulgaris successfully treated with infliximab. Case Report Ophthalmol. 2016; 7:191-194
  65. Satoh M, Namba K, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda K, Kaer L V, Iwabuchi K. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Exp Eye Res. 2016; 153: 79-89
  66. Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016; 100: 473-477
  67. Takemoto Y, Namba K, Uno T, Mizuuchi K, Iwata D, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Acta Ophthalmol. 2016; 94: e629-e636
  68. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015; 15: 181
  69. Hirooka K, Saito W, Namba K, Takemoto Y, Mizuuchi K, Uno T, Tagawa Y, Hashimoto Y, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 609-617
  70. Hase K, Namba K, Saito W, Ohno S, Ishida S. A case of tuberculous endophthalmitis successfully treated with vitrectomy followed by antituberculous agents. J Ophthalmic Inflamm Infect. 2015; 5: 14
  71. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015; 34: 321-327
  72. Namba K, Goto H, Kaburaki T, Kitaichi N, Mizuki N, Asukata Y, Fujino Y, Meguro A, Sakamoto S, Shibuya E, Yokoi K, Ohno S. A Major Review: Current Aspects of Ocular Behçet's Disease in Japan. Ocul Immunol Inflamm. 2015; 23: S1-S23
  73. Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: Clinical features, visual function, and factors affecting visual function. PLoS One. 2015；10：e0125133
  74. Tagawa Y, Namba K, Ogasawara R, Kanno H, Ishida S. A case of mature natural killer-cell neoplasm manifesting multiple choroidal lesions – Primary intraocular NK-cell lymphoma. Case Rep Ophthalmol. 2015；21：380-384
  75. Takase H, Goto H, Mizuki N, Mizuuchi K, Namba K, Ohguro N, Okada A, Sonoda K, Tomita M, Keino H, Kezuka T, Kubono R, Shibuya E, Takahashi H, Yanai R, Mochizuki M. Development and Validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophthalmol. 2015; 59: 14-20
  76. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  77. Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Namba K, Fujishima H, Miyazaki D. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol. 2014; 98: 1023-1027
  78. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD), Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis CC, Akhlagi M, Al-Dalaan A, Alekberova ZS, Ali AA, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyvat A, Carvalho L, Chen W, Ben-Chetrit E, Chams-Davatchi C, Correia JA, Crespo J, Dias C, Dong Y, Paixão-Duarte F, Elmuntaser K, Elonakov AV, Graña Gil J, Haghdoost AA, Hayani RM, Houman H, Isayeva AR, Jamshidi AR, Kaklamanis P, Kumar A, Kyrgidis A, Madanat W, Nadji A, Namba K, Ohno S, Olivieri I, Vaz Patto J, Pipitone N, de Queiroz MV, Ramos F, Resende C, Rosa CM, Salvarani C, Serra MJ, Shahram F, Shams H, Sharquie KE, Sliti-Khanfir M, Tribolet de Abreu T, Vasconcelos C, Vedes J, Wechsler B, Cheng YK, Zhang Z, Ziaei N. The Iternational Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014; 28: 338-347
  79. Kaburaki T, Namba K, Sonoda KH, Kezuka T, Keino H, Fukuhara T, Kamoi K, Nakai K, Mizuki N, Ohguro N, Ohno S, Kitaichi N, Keino H, Okada AA, Watanabe T, Takeda A, Ishibashi T, Yawata K, Iwahashi C, Mochizuki M, Sugita S, Goto H, Takamoto M, Nakahara H, Kondo Y, Shibuya E, Kimura I. Behçet’s disease ocular attack score 24: Evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol. 2014; 58: 120-130
  80. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis. 2014; 20: 171-177
  81. Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study. Ophthalmology. 2014; 121: 1877-1884
  82. Iwahashi –Shima C, Azumi A, Ohguro N, Okada A. A, Kaburaki T, Goto H, Sonoda K, Namba K, Mizuki N, Mochizuki M. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013; 57: 98-103
  83. Jin XH, Namba K, Saito W, Iwata D, Ishida S. Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab. J Ophthalmic Inflamm and Infect. 2013; 3:50
  84. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013; 57: 379-384
  85. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczek E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis. 2013; 72: 1510-1516
  86. Mizuuchi K, Kitaichi N, Namba K, Horie Y, Ishida S, Ohno S. Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013; 57: 245-251
  87. Takemoto Y, Namba K, Mizuuchi K, Ohno S, Ishida S. Two cases of subfoveal choroidal neovascularization with tubulointerstitial nephritis and uveitis (TINU) syndrome. Eur J Ophthalmol. 2013; 23: 255-7
  88. Ebihara N, Ohashi Y, Fujishima H, Fukushima A, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Uchio E, Miyazaki D. Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. Allergol Int. 2012; 61: 275-282
  89. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  90. Ishijima K, Namba K, Ohno S, Mochizuki K, Ishida S. Intravitreal injection of bevacizumab in a case of occlusive retinal vasculitis accompanied with syphilitic intraocular inflammation. Case Report Ophthalmol. 2012; 3: 434-437
  91. Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S. Correlation between elevation of serum antinuclear antibody titre and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 1081-1087
  92. Kase S, Namba K, Jin XH, Kubota K, Ishida S. Spontaneous regression of intraocular lymphoma. Ophthalmology. 2012; 119: 1083-1084
  93. Kimura K, Usui Y, Goto H, Yoshikawa H, Sugita S, Namba K, Kaburagi T, Ohguro N, Okada A, Kawahara S, Azumi A, Sakamoto T, Furuta M, Takahira M, Takamura H, Oyama T, Takai N, Sakai T, Murakami A, Hayashi N, Ushida H, Kodama T, Otani T, Mizuki N, Kojima T, Maruyama K, Kubota T. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012; 56: 383-389
  94. Kitamei H, Namba K, Kitaichi N, Wakayama A, Ohno S, Ishida S. Chickenpox chorioretinitis with retinal exudates and periphlebitis. Case Report Ophthalmol. 2012; 3:180-184
  95. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  96. Okada AA, Goto H, Ohno S, Mochizuki M, Kitaichi N, Namba K, Keino H, Watanabe T, Ishibashi T, Ito T, Sonoda K, Nakai K, Ohguro N, Sugita S, Kezuka T, Kaburaki T, Takamoto M, Mizuki N. Multicenter study of infliximab for refractory uveoretinitis in Behcet's disease. Arch Ophthalmol. 2012; 130: 592-598
  97. Sakuyama K, Meguro A, Ota M, Ishihara M, Uemoto R, Ito H, Okada E, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Yuasa T, Ohno S, Inoko H, Mizuki N. Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis. 2012; 18: 512-518
  98. Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E, Nomura E, Uemoto R, Nishide T, Namba K, Kitaichi N Morimoto S, Kaburaki T, Ando Y, Takenaka S, Nakamura J, Saeki K, Ohno S, Inoko H, MIzuki N. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: Risk factors of BTNL2 gene polymorphisms and HLA class II alleles.  Invest Ophthalmol Vis Sci. 2012; 53: 7109-7115
  99. Ito R, Ota M, Meguro A, Katsuyama Y, Uemoto R, Nomura E, Nishide T, Kitaichi N, Horie Y, Namba K, Ohno S, Inoko H, MIzuki N. Investigation of Association between TLR9 Gene Polymorphisms and VKH in Japanese Patients. Ocul Immunol Inflamm. 2011; 19: 202-205
  100. Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Ohno S, Inoko H, Mizuki N. Toll-like receptor2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis. 2011; 17: 731-736
  101. Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, Namba K, Fukagawa K, Fukushima A, Fujishima H; Japanese Society of Allergology: Japanese guideline for allergic conjunctival diseases. Allergol Int. 2011; 60:191-203
  102. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R/IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet. 2010; 42: 703-706
  103. Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Hayashi K., A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010; 26:165-74
  104. Iwata D, Kitaichi N, Ebihara A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest Ophthalmol Vis Sci. 2010; 51:2077-84
  105. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei, H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K. Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA. Exp Eye Res. 2010; 90: 41-8
  106. Kitaichi N, Kitamura M, Namba K, Ishida S, Ohno S. Elevation of surfactant protein D, a pulmonary disease biomarker,in the sera of uveitis patients with sarcoidosis. Jpn J Ophthalmol. 2010; 54:81-4
  107. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y, Namba K,Yoshida K, Song YW, Park KS, Lee EB, Inoko H, Mizuki N, Ohno S.  Association of TLR4 polymorphisms with Behcet's disease in a Korean population.  Rheumatology (Oxford). 2009; 48(6):638-42
  108. Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, Satoh H, Ohno S.  Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008; 86(8):902-7
  109. Dong Z, Namba K, Kitaichi N, Goda C, Kitamura M, Ohno S.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.  Jpn J Ophthalmol. 2008; 52(5):374-9
  110. Takemoto Y, Naruse T, Namba K, Kitaichi N, Ota M, Shindo Y, Mizuki N, Gul A, Madanat W, Chams H, Davatchi F, Inoko H, Ohno S, Kimura A.  Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet's disease.  Tissue Antigens. 2008; 72(4):347-53
  111. Kitamei H, Kitaichi N, Namba K, Kotake S, Goda C, Kitamura M, Miyazaki A, Ohno S.  Clinical features of intraocular inflammation in Hokkaido, Japan.  Acta Ophthalmol.  2009; 87(4):424-8
  112. Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S, Ishida T,Ohno S, Mizuki N, Nakashima H, Shirakawa T.  Mutation screening of the CARD15 gene in sarcoidosis.  Tissue Antigens.  2008; 71(6):564-7
  113. Horie Y, Namba K, Kitaichi N, Ohno S.  Sister cases of Behcet's disease andVogt-Koyanagi-Harada disease.  Br J Ophthalmol.  2008; 92(3):433-4
  114. Mizuuchi K, Yanagawa Y, Iwabuchi K, Namba K, Kitaichi N, Ohno S, Onoe K.  KH2-D(d)-mediated upregulation of interleukin-4 production by natural killeT-cell and dendritic cell interaction.  Immunology. 2008; 124(1):102-11
  115. Horie Y, Kitaichi N, Takemoto Y, Namba K, Yoshida K, Hirose S, Hasumi Y, OtM, Inoko H, Mizuki N, Ohno S.  Polymorphism of IFN-gamma gene anVogt-Koyanagi-Harada disease. Mol Vis. 2007; 13:2334-8
  116. Kase S, Namba K, Horie Y, Kotake S, Ohno S.  Repeated exacerbations of ocularinflammation with vitreous hemorrhage in a patient with HLA-B27 associateuveitis.  J Med  Invest. 2007; 54(3-4):350-3
  117. Kitamura M, Iwabuchi K, Kitaichi N, Kon S, Kitamei H, Namba K, Yoshida KDenhardt DT, Rittling SR, Ohno S, Uede T, Onoe K.  Osteopontin aggravateexperimental autoimmune uveoretinitis in mice.  J Immunol. 2007 178(10):6567-72
  118. Kitamei H, Kitaichi N, Yoshida K, Nakai A, Fujimoto M, Kitamura M, IwabuchK, Miyazaki A, Namba K, Ohno S, Onoe K.  Association of heat shock protein 7induction and the amelioration of experimental autoimmune uveoretinitis in mice. Immunobiology. 2007; 212(1):11-8
  119. Matsuda A, Ebihara N, Kumagai N, Fukuda K, Ebe K, Hirano K, Sotozono C, TeM, Hasegawa K, Shimizu M, Tamari M, Namba K, Ohno S, Mizuki N, Ikezawa ZShirakawa T, Hamuro J, Kinoshita S.  Genetic polymorphisms in the promoter of theinterferon gamma receptor 1 gene are associated with atopic cataracts.  Invest Ophthalmol Vis Sci. 2007; 48(2):583-9
  120. Horie Y, Takemoto Y, Miyazaki A, Namba K, Kase S, Yoshida K, Ota M, Hasumi YInoko H, Mizuki N, Ohno S.  Tyrosinase gene family and Vogt-Koyanagi-Haraddisease in Japanese patients.  Mol Vis. 2006; 12:1601-5
  121. Saito W, Saito A, Namba K, Kase S, Shiratori M, Ohno S.  Chronic panuveitiand scleritis in a patient with cryptogenic organizing pneumonia.  Jpn J Ophthalmol. 2006; 50(6):558-61
  122. Kase S, Kitaichi N, Namba K, Miyazaki A, Yoshida K, Ishikura K, Ikeda MNakashima T, Ohno S. Elevation of serum Krebs von den Lunge-6 levels in patientswith tubulointerstitial nephritis and uveitis syndrome.  Am J Kidney Dis. 2006; 48(6):935-41
  123. Biros DJ, Namba K, Taylor AW. Alpha-MSH regulates protein ubiquitination in cells.  Cell Mol Biol (Noisy-le-grand). 2006; 52(2):33-8
  124. Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, KitamurM, Ohno S, Onoe K. Amelioration of experimental autoimmune uveoretinitis (EAUwith an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidindithiocarbamate.  J Leukoc Biol.  2006; 79(6):1193-201
  125. Kase S, Namba K, Kitaichi N, Ohno S. Epstein-Barr virus infected cells in thaqueous humour originated from nasal NK/T cell lymphoma.  Br J Ophthalmol. 2006; 90(2): 244-5
  126. Namba K, Sonoda KH, Kitamei H, Shiratori K, Ariyama A, Iwabuchi K, Onoe KSaniabadi AR, Inaba S, Ishibashi T, Ohno S. Granulocytapheresis in patients withrefractory ocular Behcet's disease. J Clin Apher. 2006; 21(2):121-8
  127. Kitamura M, Kitaichi N, Takeuchi M, Kitamei H, Namba K, Yamagishi SIIwabuchi K, Onoe K, Ohno S. Decrease in the glyceraldehyde derived advanceglycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2005; 89(11):1407-9
  128. Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical featuresin tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005; 140(4): 637-41
  129. Kase S, Saito W, Yoshida K, Namba K, Osaki M, Ohgami K, Shiratori K, KitaichN, Adachi H, Ito H, Ohno S. Expression of thymidine phosphorylase in choroidamalignant melanoma associated with neovascular glaucoma. Pathol Int. 2005; 55(9):569-73
  130. Kitaichi N, Ariga T, Kase S, Yoshida K, Namba K, Ohno S. Usefulness oquantifying serum KL-6 levels in the follow-up of uveitic patients witsarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2006; 244(4): 433-7
  131. Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S. Comparative study of two sets of criteria for the diagnosis oVogt-Koyanagi-Harada's disease. Am J Ophthalmol. 2005; 139(6): 1080-5
  132. Kitaichi N, Namba K, Taylor AW. Inducible immune regulation followinautoimmune disease in the immune-privileged eye. J Leukoc Biol.  2005; 77(4): 496-502
  133. Kitaichi N, Kotake S, Shibuya H, Yamada Y, Chiba H, Namba K, Ohno S.  Increasof KL-6 in sera of uveitis patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2003; 241(11): 879-83
  134. Kotake S, Namba K, Higashi K, Goda C, Ariga T, Ogawa A, Ohno S.  The change oclinical manifestations of patients with Behcet's disease in Japan.  Adv Exp Med Biol. 2003; 528: 83-4
  135. Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells bthe immunomodulating cytokines alpha-melanocyte-stimulating hormone antransforming growth factor-beta2. J Leukoc Biol. 2002; 72(5): 946-52
  136. Taylor AW, Yee DG, Nishida T, Namba K. Neuropeptide regulation of immunityThe immunosuppressive activity of alpha-melanocyte-stimulating hormon(alpha-MSH). Ann N Y Acad Sci. 2000; 917: 239-47
  137. Namba K, Ogasawara K, Kitaichi N, Morohashi T, Sasamoto Y, Kotake S, MatsudaH, Iwabuchi K, Iwabuchi C, Ohno S, Onoe K. Amelioration of experimentaautoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposomand anti-CD40 ligand monoclonal antibody. J Immunol.  2000; 165(6): 2962-9
  138. Ito D, Ogasawara K, Matsushita K, Morohashi T, Namba K, Matsuki N, KitaichN, Inuyama Y, Hosokawa M, Nakayama E, Iwabuchi K, Onoe K.  Effective priming ocytotoxic T lymphocyte precursors by subcutaneous administration of peptidantigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies. Immunobiology. 2000; 201(5): 527-40
  139. Kitaichi N, Ogasawara K, Iwabuchi K, Nishihira J, Namba K, Onoe K, Konishi JKotake S, Matsuda H, Onoe K. Different influence of macrophage migratioinhibitory factor (MIF) in signal transduction pathway of various T cell subsets. Immunobiology. 2000; 201(3-4): 356-67
  140. Kitaichi N, Matsuda A, Kotake S, Namba K, Tagawa Y, Sasamoto Y, Ogasawara K,Iwabuchi K, Onoe K, Matsuda H, Nishihira J. Inhibition of experimental autoimmunuveoretinitis with anti-macrophage migration inhibitory factor antibodies. Curr Eye Res. 2000; 20(2): 109-14
  141. Matsuki N, Ogasawara K, Takami K, Namba K, Takahashi A, Fukui Y, Sasazuki T,Iwabuchi K, Good RA, Onoe K. Prevention of infection of influenza virus in DQmice, a human model, by a peptide vaccine prepared according to the cassetttheory. Vaccine. 1999; 17(9-10): 1161-8
  142. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, Onoe KMatsuda H, Nishihira J. Prominent increase of macrophage migration inhibitorfactor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci.  1999; 40(1): 247-50
  143. Namba K, Ogasawara K, Kitaichi N, Matsuki N, Takahashi A, Sasamoto Y, KotakeS, Matsuda H, Iwabuchi K, Ohno S, Onoe K. Identification of a peptide inducinexperimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice.  Clin Exp Immunol. 1998; 111(2): 442-9
  144. Itoh Y, Kajino K, Ogasawara K, Takahashi A, Namba K, Negishi I, Matsuki NIwabuchi K, Kakinuma M, Good RA, Onoe K. Interaction of pigeon cytochromc-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule. Proc Natl Acad Sci U S A. 1997; 94(22): 12047-52
  145. Itoh Y, Kajino K, Ogasawara K, Katoh M, Namba K, Takami K, Iwabuchi KBraunstein NS, Onoe K. Determination of the allele-specific antigen-binding siteon I-Ak and I-Ab molecules. Eur J Immunol. 1996; 26(6): 1314-21